missing translation for 'onlineSavingsMsg'
Learn More

Drucken

StemPro™ CD34+ Cell Kit

Marke: Gibco A14059

Artikelnummer. 12694757

Dieser Artikel wurde eingestellt und ist leider nicht mehr verfügbar. Sehen Sie sich das Produkt an, um alternative Produktvorschläge zu sehen oder kontaktieren Sie unseren Technischen Support unter 056 618 41 11.
Alternative Produkte anzeigen »

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Diese Produkte könnten Sie auch interessieren

Artikelnummer. 11580356

Gibco™ StemPro™-34 SFM (1x)

584.00 CHF / 500 Milliliter

Beschreibung

StemPro™ CD34+ cells are pooled Human Hematopoietic Progenitor cells (HPCs) derived from the umbilical cord blood of mixed donors. Along with 0.5×10⁶ pooled donor cord blood-derived CD34+ cells, this kit includes StemPro™-34 SFM basal liquid medium and frozen StemPro™-34 Nutrient Supplement to facilitate the immediate culturing of the StemPro™ CD34+ cells upon arrival or when recovering from cryopreservation storage.

With the StemPro™ CD34+ Cell Kit You Get:

≥90% purity of the desired CD34+ cell population

Each vial of cells contains 0.5×10⁶ CD34+ cells with full traceability

StemPro™-34 SFM manufactured following cGMP and ISO13485

High reprogramming efficiency to iPSCs

Custom sizes available upon request

Included in this kit are:

One vial containing one ml of 0.5×10⁶ cells/ml pooled donor cord blood-derived CD34+ cells

500 ml StemPro™-34 SFM basal liquid medium

13 ml frozen StemPro™-34 Nutrient Supplement

Hematopoietic Progenitor Cells
Hematopoietic progenitor cells (HPCs) or hematopoietic stem cells (HSCs) can be found in the blood, bone marrow, umbilical cord blood, or derived from Embryonic Stem Cells (ESCs) or induced pluripotent stem cells (iPSCs). They are multipotent stem cells capable of forming every cell lineage in the blood and immune system. Hematopoietic progenitor cells (HPCs) are non-adherent, with a small, round morphology. A fundamental property of these cells is their capacity to self-renew, thus providing, in principle, a limitless source of daughter cells with the same functional properties. Several cell surface markers used for identifying human HPCs/HSCs include CD34+, CD59+, Thy1/CD90+, CD38 lo/-, C-kit/CD117+, Lin-.

Common Applications
Hematopoietic stem cells (HSCs) are most commonly used in transplantation therapies to treat illnesses such as leukemia, lymphoma, and sickle cell diseases by reconstituting a patient's hematopoietic cell system.

High Purity Stem Cells for Higher Reprogramming Efficiency
HPCs/HSCs can be reprogrammed to induced pluripotent stem cells (iPSCs) for use as disease models in stem cell research. StemPro™ CD34+ cells have ≥90% CD34+ cells, as determined by Flow Cytometry, affording higher reprogramming efficiency than less pure populations. Protocols using CytoTune™-iPS Sendai Reprogramming Kit are available on our website and included in the product insert.

Isolation of CD34+ Cells from Cord Blood
StemPro™ CD34+ primary cord blood cells from multiple human donors originating and collected in the United States are pooled and then enriched for the CD34+ cell population using immunomagnetic CD34 MicroBeads. Pooling the cord blood from multiple donors reduces the lot-to-lot variability of the product. The cells are derived from tissue obtained from accredited institutions through an IRB (Institutional Review Board) approved donor program and are negative for HIV and Hepatitis B.

Quality control
QC for the StemPro™ CD34+ cells includes testing for the following: mycoplasma, sterility, endotoxin, and FACS profile.

QC for StemPro-34 SFM includes testing for the following: Sterility, pH, endotoxin, osmolality, Hepatitis B Surface Antigen, HIV 1&2 antibody, HCV antibody, and CD34+ cell performance assay.

Serum Free Medium Developed for CD34+ Cell Expansion
StemPro™-34 SFM is comprised of a basal liquid medium and frozen StemPro™-34 Nutrient Supplement. This serum-free media system was developed to support the growth of human CD34+ hematopoietic progenitor cells. Sera can vary from lot to lot in its ability to support cell-specific growth in culture. Serum-free culture systems eliminate this major variable in the study of hematopoiesis ex vivo. StemPro™-34 SFM can be purchased separately.

See a list of selected publications citing the Sendai virus for iPSC generation here.

For Research Use Only. Not for use in diagnostic procedures.

Spezifikation

Inhalt und Lagerung	2 to 8°C (StemPro™-34 SFM media), –5° to –20°C (StemPro 34 supplement)
Zur Verwendung mit (Anwendung)	Stem cell culture, stem cell engineering and reprogramming
Menge	1 Kit(s)

Zelltyp	Stem Cells (Hematopoietic)
Enthält	One vial containing one mL of 0.5 x 106 cells/mL pooled donor cord blood-derived CD34+ cells, 500mL StemPro™-34 SFM basal liquid medium, 13mL frozen StemPro™-34 Nutrient Supplement
Bemerkungen	StemPro™ CD34+ Cell Kit, 1 Kit, 0.5 x 106 Cells/mL Stem Cells (Hematopoietic) Cell Type, Newborn (14 days or less), Serum-Free, Normal Donor Attributes, Cryopreserved, StemPro™-34 SFM Media Recommendation, Human Species

Produktvorschläge Dokumentation

Dokumentation

Product Information

Manuals

User Guide: StemPro-34 Medium and CD34+ Cell Kit Version: 4.0 DateigrößeVersion: 186.8 kB

Berichtigung von Produktinhalten

Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.

Name des Produkts

StemPro™ CD34+ Cell Kit > 0.5 x 106 cells/mL

Ihr Name

E-Mail Adresse *

Art der Problems *

Detaillierte Beschreibung des Problems/der Anfrage *

Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.

Abbrechen Absenden

Vielen Dank, dass Sie uns helfen, unsere Website zu verbessern. Ihr Feedback wurde übermittelt

Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.

Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur